Reference

1. Zayed MA, Fahmey MA, Hawash MA and El-Habeeb AA. Mass spectrometric investigation of buspirone drug in comparison with thermal analyses and MO-calculations. Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy, 2007; 67(2): pp.522-530.
2. Ary K, Rona K, Ondi S and Gachalyi B. 1998. High-performance liquid chromatographic method with coulometric detection for the determination of buspirone in human plasma by means of a column-switching technique. Journal of Chromatography A, 1998; 797(1-2): pp.221-226.
3. Patil, V., Labade, S., Khilare, C. and Sawant, S. A Molecular Bridge-Like Binding Mode of Buspirone to BSA: Multispectroscopic and Molecular Docking Investigation. Chemical Data Collections 2022; 40: p.100892.
4. Kartal M, Khedr A and Sakr A. Liquid chromatographic method for the analysis of buspirone HCl and its potential impurities. Journal of chromatographic science, 2000; 38(4): pp.151-156.
5. https://pubchem.ncbi.nlm.nih.gov/compound/Buspirone#section=Pharmacology-and-Biochemistry
6. https://go.drugbank.com/drugs/DB00490
7. https://en.wikipedia.org/wiki/Buspirone#Pharmacology
8. Spooner N. Dried blood spot sampling for quantitative bioanalysis, time for a revolution. Bioanalysis, 2010; 2: 1781.
9. DU Q, SUN J, KANG LJ, & YAN GW. Determination of buspirone hydrochloride and its active metabolite in plasma by HPLC. Chinese Journal of Pharmaceutical Analysis, 2003; 23(1): 56-58.
10. Foroutan SM, Zarghi A, Shafaati A R, & Khoddam A. Simple high-performance liquid chromatographic determination of buspirone in human plasma. Il Farmaco, 2004; 59(9): 739-742.
11. Péhourcq F. Rapid high?performance liquid chromatographic measurement of buspirone in human plasma after overdose. Biomedical Chromatography, 2004; 18(9): 637-640.
12. Odontiadis J, & Franklin M. Simultaneous quantitation of buspirone and its major metabolite 1-(2-pyrimidinyl) piperazine in human plasma by high-performance liquid chromatography with coulometric detection. Journal of pharmaceutical and biomedical analysis, 1996; 14(3): 347-351.
13. Ary K, Rona K, Ondi S, & Gachalyi B. High-performance liquid chromatographic method with coulometric detection for the determination of buspirone in human plasma by means of a column-switching technique. Journal of Chromatography A, 1998; 797(1-2): 221-226.
14. Kristjánsson F. Sensitive determination of buspirone in serum by solid-phase extraction and two-dimensional high-performance liquid chromatography. Journal of Chromatography B: Biomedical Sciences and Applications, 1991; 566(1): 250-256.
15. Gannu R, Yamsani SK, Palem CR, Yamsani VV, Kotagiri H, & Yamsani MR. Development of high performance liquid chromatography method for buspirone in rabbit serum: Application to pharmacokinetic study. Analytica chimica acta, 2009; 647(2): 226-230.
16. Kim KT, Lee JY, Park JH, Kim MH, Kim JS, Shin HJ, ... & Kim DD. Development of HPLC method for the determination of buspirone in rat plasma using fluorescence detection and its application to a pharmacokinetic study. Chemical and Pharmaceutical Bulletin, 2016; 64(11): 1582-1588.
17. Aparicio X, Campos A, Gras J, Fernandez E, & Gelpí E. Determination of a buspirone metabolite in plasma samples. Journal of Pharmaceutical and Biomedical Analysis, 1988; 6(6-8): 945-948.
18. Franklin M. Determination of plasma buspirone by high-performance liquid chromatography with coulometric detection. Journal of Chromatography B: Biomedical Sciences and Applications, 1990; 526: 590-596.
19. Diaz-Marot A, Puigdellivol E, Salvatella C, Comellas L, & Gassiot M. Determination of buspirone and 1-(2-pyrimidinyl) piperazine in plasma samples by high-performance liquid chromatography. Journal of Chromatography B: Biomedical Sciences and Applications, 1989; 490: 470-473.
20. Chew WM, Xu MJ, Cordova CA, & Chow HS. Quantification of a cytochrome P450 3A4 substrate, buspirone, in human plasma by liquid chromatography–tandem mass spectrometry. Journal of Chromatography B, 2006; 844(2): 235-239.
21. Green R, Houghton R, & Jacobs S. Determination of buspirone and its metabolite 1-(2- pyrimidinyl)-piperazine in human plasma by liquid chromatography tandem mass spectrometry. Chromatographia, 2004; 59 (Suppl 2): S197-S201.
22. Kerns EH, Rourick RA, Volk KJ, & Lee MS. Buspirone metabolite structure profile using a standard liquid chromatographic-mass spectrometric protocol. Journal of Chromatography B: Biomedical Sciences and Applications, 1997; 698(1-2): 133-145.
23. Joshi P, Rao S, Singh M, Vig N, Singh AK, Rajawat NS, & Gupta A. A sensitive LC-ESI- MS/MS method for the quantification of low concentrations of buspirone in human plasma. Analytical Methods, 2013; 5(24): 7014-7021.
24. Kivistö KT, Laitila J, Mårtensson K, & Neuvonen PJ. Determination of buspirone and 1- (2-pyrimidinyl)-piperazine (1-PP) in human plasma by capillary gas chromatography. Therapeutic drug monitoring, 1999; 21(3): 317.
25. Lai CT, Véronique AMT, Rauw GA, Bateson AN, Martin IL, & Baker GB. Rapid, sensitive procedure to determine buspirone levels in rat brains using gas chromatography with nitrogen–phosphorus detection. Journal of Chromatography B: Biomedical Sciences and Applications, 1997; 704(1-2): 175-179.
26. Kurien J, Kurian T, & Mathew A. Simple spectrophotometric determination of buspirone hydrochloride in bulk drug and pharmaceutical dosage forms. Science & Society, 2012; 10: 147.
27. Amanlou M, Keivani S, Sadri B, Gorban-Dadras O, & Souri E. Simple extractive colorimetric determination of buspirone by acid-dye complexation method in solid dosage form. Research in Pharmaceutical Sciences, 2009; 4(1): 11-18.
28. Dhandapani H, Hemamrutha S, Lakshmi Sravanthi K, & Swetha J. Spectrophotometric estimation of buspirone hydrochloride in bulk and its pharmaceutical formulation. Int J of Pharma Sciences and Research, 2010; 1(4).
29. Kurien J, & Kurian T. A sensitive spectrophotometric method for the quantitative determination of buspirone hydrochloride in pharmaceutical formulations. Hygeia JD Med, 2012; 4: 6-14.
30. Azmi SNH, Al-Ghafri LT, Al-Ghafri SS, & Al-Haribi MM.  Determination of buspirone HCL in commercial dosage forms by extractive spectrophotometric method and comparison by HPLC method. Sci. J. Anal. Chem, 2015; 3: 91.
31. Rao B, Nagendrakumar AVD, Maiti S, & Raja G. Validated RP-HPLC method for the determination of buspirone in pharmaceutical formulations. Chromatography Research International, 2011.
32. Azeem A, Rizwan M, Ahmad FJ, Iqbal Z, Khar RK, Aqil M, & Talegaonkar S. Development and validation of a stability-indicating LC-UV method for rapid analysis of buspirone in pharmaceutical dosage forms. Acta Chromatographica, 2009; 21(2): 283-297.
33. Zaxariou M, & Panderi I. Development and validation of a high-performance liquid chromatographic method for the determination of buspirone in pharmaceutical preparations. Journal of pharmaceutical and biomedical analysis, 2004; 35(1): 41-50.
34. Khedr A, & Sakr A. Stability-indicating high-performance liquid chromatographic assay of Buspirone HCI. Journal of chromatographic science, 1999; 37(12): 462-468.
35. Azmi SNH, Al-Ghafri LT, Al-Ghafri SS, & Al-Haribi MM. Determination of buspirone HCL in commercial dosage forms by extractive spectrophotometric method and comparison by HPLC method. Sci. J. Anal. Chem, 2015; 3: 91.
36. Kartal M, Khedr A, & Sakr A. Liquid chromatographic method for the analysis of buspirone HCl and its potential impurities. Journal of chromatographic science, 2000; 38(4): 151-156.
37. Pilvenyt? G, Kazlauskien? D, Marksa M, & Bezruk I. Determination of buspirone, fluoxetine, escitalopram and paroxetine by HPTLC after SPE extraction. In The 22nd annual international scientific-practical conference„ BaltPharm Forum 2019 “„Pharmacists as drug experts: their role in health care system“: April 13-14, 2019 Kaunas, Lithuania: book of abstracts/Lithuanian Pharmaceutical Association. Pharmacists ‘Society of Latvia. Pharmaceutical Society of; Edited by: Vilma Petrikait?. Kaunas: Lithuanian Pharmaceutical Association (LFS), 2019.